Benazepril - Lostensin

Benazepril /Lostensin classification

Antihypertensive agent ACE inhibitor

Benazepril/Lostensin

Cautious use: renal impairment, renal-artery stenosis; patient with hypovolemia, receiving diuretics, undergoing dialysis; patients in whom excessive hypotension would present a hazard (cardiovascular insufficiency) CHF; hepatic impairment; diabetes mellitus

Benazepril pregnancy category:

D second and third trimester; C first trimester

Benazepril (generic name)

Lostensin (brand name)

Benazepril /Lostensin: action & therapeutic effect

Lower blood pressure by specific inhibition of the angiotensin-converting enzyme (ACE) and thus by decreasing angiotensin II (a potent vascoconstrictor) and aldosterone secretion

Benazepril/Lostensin: drug interaction:

Postassium sparing diuretics may increase the risk of hyperkalemia. May increase lithium levels to toxicity

Benazepril/Lostensin patient & family education

do not use salt substitutes unless recommended, report swelling of face, eyes, lips or tongue or difficulty breathing

Benazepril/Lostensin Adverse effects

hypotention, headache, dizziness fatigue, weakness, hyperkalemia, Nausea diarrhea

Benazepril/Lostensin Lab test

monitor serum potassium levels

Benazepril/Lostensin use

treatment of mild to moderate hypertension